[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 17, 1977

Corynebacterium Sepsis in Oncology PatientsPredisposing Factors, Diagnosis, and Treatment

Author Affiliations

From the Johns Hopkins Oncology Center (Drs Pearson and Braine) and the Bacteriology Laboratories, the Baltimore City Hospitals (Dr Rathbun), Baltimore. Dr Pearson is now with the Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore.

JAMA. 1977;238(16):1737-1740. doi:10.1001/jama.1977.03280170031021
Abstract

Bacteremia due to a newly described species of Corynebacterium was identified in 12 patients during a two-year period. Infection occurred after a long period of hospitalization, extended granulocytopenia, and treatment with several antibiotics. Breaks in the mucocutaneous surfaces were the origin of infection in eight patients. All patients had evidence of colonization reported by cultures before infection. The invading organism caused death in three patients. Vancomycin hydrochloride was the antibiotic of choice. Corynebacterium is increasingly recognized as a primary cause of morbidity and mortality of patients with tumors.

(JAMA 238:1737-1740, 1977)

×